Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
No open-market purchases or sales by Medicinova Inc insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Medicinova Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −4 vs. Q2 2023
- Shares held
- 5.01M
- −374.8K (−7.0%) vs. Q2 2023
- Total value
- $10.5M
- −$1.93M (−15.6%) vs. Q2 2023
- New holders
- 3
- 5 more added
- Sold out
- 7
- 12 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNOV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $6.84M |
| Q1 2026 | 30 | $7.40M |
| Q4 2025 | 33 | $6.88M |
| Q3 2025 | 26 | $6.49M |
| Q2 2025 | 23 | $6.77M |
| Q1 2025 | 28 | $7.60M |
| Q4 2024 | 30 | $11.0M |
| Q3 2024 | 30 | $10.4M |
| Q2 2024 | 33 | $7.04M |
| Q1 2024 | 35 | $6.78M |
| Q4 2023 | 34 | $7.25M |
| Q3 2023 | 30 | $10.5M |
| Q2 2023 | 34 | $12.4M |
| Q1 2023 | 40 | $12.1M |
| Q4 2022 | 41 | $12.7M |
| Q3 2022 | 35 | $14.9M |
| Q2 2022 | 35 | $17.6M |
| Q1 2022 | 32 | $19.0M |
| Q4 2021 | 42 | $20.4M |
| Q3 2021 | 39 | $29.0M |
| Q2 2021 | 55 | $35.8M |
| Q1 2021 | 60 | $59.5M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Medicinova Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,105,941 | $2.31M | 2.04% | 00.0% | Unchanged |
| BlackRock Inc. | 695,597 | $1.45M | 0.00% | −35,772−4.9% | Reduced |
| Vanguard Group Inc | 616,843 | $1.29M | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 447,957 | $936.2K | 0.00% | −50,300−10.1% | Reduced |
| Geode Capital Management, LLC | 435,733 | $910.9K | 0.00% | −1,514−0.3% | Reduced |
| Millennium Management LLC | 214,806 | $448.9K | 0.00% | −5,900−2.7% | Reduced |
| Dimensional Fund Advisors LP | 157,942 | $330.1K | 0.00% | +43,169+37.6% | Added |
| Northern Trust Corp | 153,699 | $321.2K | 0.00% | −488−0.3% | Reduced |
| Renaissance Technologies LLC | 149,600 | $313.0K | 0.00% | +2,700+1.8% | Added |
| Bridgeway Capital Management, LLC | 145,147 | $303.4K | 0.01% | 00.0% | Unchanged |
| State Street Corp | 142,298 | $297.4K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 135,376 | $282.9K | 0.00% | −32,836−19.5% | Reduced |
| HRT Financial LP | 124,884 | $261.0K | 0.00% | −17,566−12.3% | Reduced |
| Bank of New York Mellon Corp | 119,993 | $250.8K | 0.00% | −163−0.1% | Reduced |
| Barclays PLC | 103,800 | $216.9K | 0.00% | −8,600−7.7% | Reduced |
| Bank of America Corp | 86,659 | $181.1K | 0.00% | −21,800−20.1% | Reduced |
| Schonfeld Strategic Advisors LLC | 42,200 | $88.2K | 0.00% | −100−0.2% | Reduced |
| Capricorn Fund Managers Ltd | 30,459 | $63.7K | 0.02% | +30,459 | New |
| Price T Rowe Associates Inc | 20,700 | $44.0K | 0.00% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 17,843 | $37.3K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 14,955 | $31.3K | 0.00% | +143+1.0% | Added |
| Susquehanna International Group, LLP | 13,134 | $27.4K | 0.00% | +13,134 | New |
| WealthTrust Axiom LLC | 12,500 | $26.1K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,280 | $19.4K | 0.00% | +667+7.7% | Added |
| Morgan Stanley | 6,213 | $13.0K | 0.00% | −5,433−46.7% | Reduced |
| Cutler Group LP | 2,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 412 | $861 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 358 | $748 | 0.00% | +5+1.4% | Added |
| Northwestern Mutual Wealth Management Co | 305 | $637 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 32 | $67 | 0.00% | +32 | New |
| Bank of Montreal | 0 | $0 | 0.00% | −127,300−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −91,828−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −31,117−100.0% | Sold out |
| Bank Julius Baer & Co. Ltd, Zurich | 0 | $0 | 0.00% | −18,650−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −15,492−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −289−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |